Cancer and Leukemia Group B
Cancer and Leukemia Group B
批准号:
7633466
负责人:
CLIFFORD A HUDIS
金额:
$21.4万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-30 至 2015-03-31
关键词:
AllyAreaBasic ScienceCancer CenterCancer HospitalCancer and Leukemia Group BClinicalClinical ResearchCommitDiseaseGoalsGrantHospitalsInstitutesInstitutionIntentionLeadershipMemorial Sloan-Kettering Cancer CenterModalityOutpatientsPatient CarePatientsPhysiciansPoliciesPositioning AttributeResearchResearch TrainingScientistTestingTraining Programsanticancer researchpatient populationprogramsresearch facilitysuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Memorial Sloan-Kettering Cancer Center (MSKCC) is the largerst privately owneed nonprofit cancer center in the world. The Center consists of 3 corporations. Memorial Hospital for Cancer and Allied Diseases, foundin in 1884 is the clinical unit; Sloan-Kettering Institute for Cancer Research, founded in 1945 is the basic research unit; and Memorial Sloan-Kettering Cancer Center, founded in 1960 is the unit that formulates policies and long-range plans and coordinates the activities of the hospital and the institute. MSKCC is a free-standing institution committed to exceptional in-patient and out-patient care, leading edge research and superb clinical and research training programs. MSKCC's clinical research programs are synonymous with those of the Cancer and Leukemia Group B (CALGB). Physician-scientists at MSKCC hold leadership positions in the CALGB across an array of disease-specific areas and treatment modalities, with significant administrative responsibilities for the group. Scientific and clinical research programs at MSKCC are created with the intention of ultimately testing them, when possible, in the larger patient populations offered by our participation in the CALGB. During the next six years, MSKCC will continue to expand its clinical and research facilities as well as its research and training programs. The enclosed grant offers examples of MSKCC contributions to the success of the CALGB and support for MSKCC's continued participation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MEMORIAL HOSPITAL AND CANCER AND ACUTE LEUKEMIA GROUP B
-
批准号:6513396
-
项目类别:
-
资助金额:$24.84万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
Cancer and Leukemia Group B
-
批准号:8063655
-
项目类别:
-
资助金额:$20.12万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:6745586
-
项目类别:
-
资助金额:$32.04万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:6885323
-
项目类别:
-
资助金额:$18.39万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:7498407
-
项目类别:
-
资助金额:$26.64万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
Cancer and Leukemia Group B
-
批准号:8450282
-
项目类别:
-
资助金额:$19.47万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
Cancer and Leukemia Group B
-
批准号:8249471
-
项目类别:
-
资助金额:$21.24万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:6596323
-
项目类别:
-
资助金额:$34.65万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:7253896
-
项目类别:
-
资助金额:$26.43万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:7048549
-
项目类别:
-
资助金额:$18.94万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
Cancer and Leukemia Group B
-
批准号:7896735
-
项目类别:
-
资助金额:$21.9万
-
财政年份:1998
-
负责人:CLIFFORD A HUDIS
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: